Skip to main content
SLAS Europe 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Short Course
Short Course
On Demand
On Demand
Back

Raphael Tomasi, PhD (he/him/his)

CTO
Okomera, France

Raphaël TOMASI has been developing a unique droplet microfluidic technology to perform multiplexed 3D cell culturing on chip since 2013. He co-invented this technology during his Ph.D. in microfluidics, between 2013 and 2016, in Charles BAROUD’s laboratory at Ecole Polytechnique (Paris, France). Then, he continued developing the technology in the lab, as well as the associated business opportunity, at Institut Pasteur (Paris, France) until 2020. In mid-2020, he cofounded Okomera to commercialize this technology for precision cancer medicine. Based in Paris, Okomera is launching its first product to automate drug testing on cancer cells from patient biopsies for precision cancer medicine. Raphaël TOMASI leads the technological development of Okomera as CTO.

Presentation(s):